anesthesia guidelines glp-1 Glucagon-Like Peptide-1 Receptor Agonists in Perioperative Care A narrative review of glucagon-like

Understanding these conflicts helps ensure safe, successful treatment with semaglutide or tirzepatide

It is currently in Phase 2 clinical trials for the treatment of overweight and obesity

This content is for general informational and marketing purposes only and does not constitute medical advice

Although, in the last 10 years, the use of GLP-1 RAs, especially semaglutide and liraglutide, has increased, its clinical implications and how it affects metabolic parameters have yet to be fully consolidated

In a discussion about the physician survey, the President of Omada Health, Wei-Li Shao, told Fierce Healthcare that, We believe that the decision to start, stop, or continue a GLP-1 should be made in the medical home between the patient and their primary care physician. The concept of the medical home has been defined by the American Academy of Pediatrics as, An approach to providing comprehensive and high quality primary care.that is accessible, family-centered, continuous, comprehensive, coordinated, compassionate, and culturally effective. AAP also notes that a medical home, is not a building or place, extending beyond the walls of a clinical practice.A medical home builds partnerships with clinical specialists, families and community resources